event-trade登录编辑
Seeking AlphaCodex · 实盘不做把握 8/10
北京时间·🕒 发布 04:11:17时区推断·⟳ 抓取 04:11:23·⚡ 决策 08-04 12:18:11 +8h06m·84.5 天前

Medifast二季度亏损小于预期、全年亏损指引改善

二季度GAAP EPS为-0.28美元、收入7640万美元,均好于预期。

📄 原文Seeking Alpha↗ 原文
Medifast GAAP EPS of -$0.28 beats by $0.37, revenue of $76.4M beats by $3.7M
- Medifast press release (MED): Q2 GAAP EPS of -$0.28 beats by $0.37. - Revenue of $76.4M (-27.7% Y/Y) beats by $3.7M.…
不做 Medifast(MED.US)
同一具体财报催化已命中08-03 20:14 UTC已处理事件“Medifast公布二季度业绩,亏损小于预期并改善全年亏损指引”,本条不重复出卡。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)

研究档案

🔎 新鲜度:最早出现 2026-08-03 · 扩散 high · price-in 风险 high ↗

关键理由

  • 二季度GAAP EPS为-0.28美元、收入7640万美元,均好于预期。
  • 全年2026年收入指引27000万至30000万美元接近27970万美元一致预期,全年每股亏损-0.25至-1.75美元好于-1.85美元一致预期。

主要风险

  • 同一财报催化已在已处理消息库中形成过决策,本条为Seeking Alpha重复转述。
工具调用 · 历史记录,结果未知(1 种)
  • search_processed_events · 结果未知

原文全文

展开原文 · 715 字
- Medifast press release (MED): Q2 GAAP EPS of -$0.28 beats by $0.37.
- Revenue of $76.4M (-27.7% Y/Y) beats by $3.7M.
- Revenue: $76.4 million, with revenue per active earning coach of $6,529
- Independent active earning coaches of 11,700
- The company expects third quarter 2026 revenue to be in the range of $60 million to $80 million and third quarter 2026 loss per share to be in the range of $0.15 to $0.65. This excludes any one-time costs associated with the execution of the company's Catalyst initiatives.
- The company expects full year 2026 revenue to be in the range of $270 million to $300 million vs $279.7M consensus and full year 2026 loss per share to range from $0.25 to $1.75 vs -$1.85 consensus

决策记录链 · 只追加

每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。

这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。